Hyperlipidemia NCEP recommendations for drug therapy of high-risk hyperlipidemia in children and adolescents: Difference between revisions
Jump to navigation
Jump to search
(Created page with "'''For patient information click here''' {{CMG}} {{DiseaseDisorder infobox | Name = Hyperlipidemia | ICD10 = {{ICD10|E...") |
|||
Line 17: | Line 17: | ||
* Consider drug therapy in children >10 years of age (usually wait until menarche for females) and after a 6- to 12-month trial of fat- and cholesterol-restricted dietary management. | * Consider drug therapy in children >10 years of age (usually wait until menarche for females) and after a 6- to 12-month trial of fat- and cholesterol-restricted dietary management. | ||
* Consider drug therapy if | * Consider drug therapy if | ||
**LDL level remains >4.90 mmol/L (190 mg/dL) or | **LDL level remains >4.90 mmol/L (190 mg/dL) or | ||
**LDL remains >4.10 mmol/L (160 mg/dL) and | **LDL remains >4.10 mmol/L (160 mg/dL) and | ||
* There is a positive family history of premature cardiovascular disease >2 other risk factors are present in the child or adolescent after vigorous attempts to control these risk factors. | * There is a positive family history of premature cardiovascular disease >2 other risk factors are present in the child or adolescent after vigorous attempts to control these risk factors. | ||
** Referral to specialized lipid center may be deemed appropriate. | ** Referral to specialized lipid center may be deemed appropriate. | ||
** Treatment goal | ** Treatment goal | ||
*** Minimal, LDL <3.35 mmol/L (130 mg/dL) | *** Minimal, LDL <3.35 mmol/L (130 mg/dL) | ||
*** Ideal, LDL <2.85 mmol/L (110 mg/dL) | *** Ideal, LDL <2.85 mmol/L (110 mg/dL) |
Revision as of 13:43, 29 October 2011
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Template:DiseaseDisorder infobox
WikiDoc Resources for Hyperlipidemia NCEP recommendations for drug therapy of high-risk hyperlipidemia in children and adolescents |
Articles |
---|
Media |
Evidence Based Medicine |
Clinical Trials |
|
Guidelines / Policies / Govt |
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
|
Healthcare Provider Resources |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Overview
Original Recommendations of the National Cholesterol Education Program (NCEP) Expert Panel
- Consider drug therapy in children >10 years of age (usually wait until menarche for females) and after a 6- to 12-month trial of fat- and cholesterol-restricted dietary management.
- Consider drug therapy if
- LDL level remains >4.90 mmol/L (190 mg/dL) or
- LDL remains >4.10 mmol/L (160 mg/dL) and
- There is a positive family history of premature cardiovascular disease >2 other risk factors are present in the child or adolescent after vigorous attempts to control these risk factors.
- Referral to specialized lipid center may be deemed appropriate.
- Treatment goal
- Minimal, LDL <3.35 mmol/L (130 mg/dL)
- Ideal, LDL <2.85 mmol/L (110 mg/dL)